i think mama rathjen said in one of her recent talks, the one that windshift posted the video link for, that becuase GAD has approved treatments and 210 is a brand new method of action the fda would be quite strict around approval.
trialing similar dieseases where there is no approved treatment they felt would be easier when meeting with the fda. which they will have to do prior to any phase 3.
BNO Price at posting:
59.5¢ Sentiment: Buy Disclosure: Held
